Neogen Chemicals Peer Comparison
NSE: NEOGEN | BSE: 542665
₹2,856.30
As on 12-Nov-2026IST
Market cap
₹8,583 Cr
Revenue (TTM)
₹1,013 Cr
P/E Ratio
212.3
P/B Ratio
5.4
Div. Yield
0 %
| Neogen Chemicals | Atul | DCM Shriram | Foseco India | Grauer & Weil | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
8,583 | 15,330 | 14,083 | 4,738 | 3,512 |
Revenue (₹ Cr) |
1,013 | 6,969 | 15,312 | 872 | 1,270 |
Net Profit (₹ Cr) |
40.07 | 780.42 | 1,380.21 | 125.26 | 155.34 |
Net Margin (%) |
3.91 | 10.87 | 8.94 | 13.97 | 11.77 |
RoE (%) |
3.38 | 12.06 | 14.47 | 11.78 | 14.03 |
Price to Earnings |
212.34 | 19.86 | 10.21 | 40.40 | 22.61 |
Price-To-Book |
5.44 | 2.33 | 1.67 | 4.23 | 3.10 |
Income Statement (₹ Cr)
| Neogen Chemicals | Atul | DCM Shriram | Foseco India | Grauer & Weil | |
|---|---|---|---|---|---|
|
Operating Revenue
|
861.96 | 6,273.54 | 13,538.15 | 643.42 | 1,190.20 |
|
Total Income
|
868.10 | 6,477.07 | 13,790.27 | 660.26 | 1,239.78 |
|
Total Expenditure
|
724.67 | 5,243.38 | 12,096.61 | 519.37 | 995.77 |
|
EBITDA
|
137.29 | 1,030.16 | 1,441.54 | 124.05 | 194.44 |
|
Depreciation
|
27.52 | 322.13 | 502.35 | 13.32 | 24.45 |
|
EBIT
|
109.77 | 708.03 | 939.19 | 110.73 | 169.99 |
|
Interest
|
75.11 | 17.43 | 175.66 | 0.30 | 3.67 |
|
Other Income
|
6.14 | 203.53 | 252.12 | 16.84 | 49.58 |
|
Exceptional Items
|
-14.08 | -- | -23.39 | -21.66 | -- |
|
Profit before Tax
|
41.08 | 900.50 | 992.26 | 105.61 | 215.90 |
|
Provision for Tax
|
12.33 | 211.11 | 136.28 | 30.74 | 51.87 |
|
Profit after Tax
|
28.75 | 689.39 | 855.98 | 74.87 | 164.03 |
Liabilities (₹ Cr)
| Neogen Chemicals | Atul | DCM Shriram | Foseco India | Grauer & Weil | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
816.25 | 6,221.96 | 7,711.97 | 1,036.25 | 1,081.63 |
|
Minority Interest
|
-- | 74.57 | 20.86 | 83.64 | -- |
|
Non-Current Liabilities
|
897.95 | 451.12 | 2,647.26 | 58.66 | 45.58 |
|
Current Liabilities
|
1,187.67 | 1,283.70 | 5,887.30 | 189.66 | 317.53 |
|
Total Liabilities
|
2,901.87 | 8,031.35 | 16,276.68 | 1,368.21 | 1,444.73 |
Assets (₹ Cr)
| Neogen Chemicals | Atul | DCM Shriram | Foseco India | Grauer & Weil | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
1,509.36 | 3,814.10 | 8,533.24 | 817.78 | 583.46 |
|
Current Assets
|
1,392.51 | 4,217.25 | 7,726.18 | 550.43 | 861.27 |
|
Total Assets
|
2,901.87 | 8,031.35 | 16,276.68 | 1,368.21 | 1,444.73 |
|
Total Debt*
|
1,329.89 | 179.76 | 2,812.49 | 0.00 | 8.72 |
|
Net Current Assets
|
204.84 | 2,933.55 | 1,838.88 | 360.77 | 543.74 |
|
Contingent Liabilities
|
156.69 | 162.71 | 78.08 | 1.30 | 53.98 |
Cashflow (₹ Cr)
| Neogen Chemicals | Atul | DCM Shriram | Foseco India | Grauer & Weil | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-231.48 | 1,022.77 | 1,233.80 | 97.62 | 151.86 |
|
Cash Flow from Investing Activities
|
-410.26 | -894.55 | -1,240.63 | -88.89 | -183.82 |
|
Cash from Financing Activities
|
641.71 | -98.46 | -306.83 | -16.77 | -27.69 |
|
Net Cash Inflow / Outflow
|
-0.03 | 29.76 | -313.66 | -8.04 | -59.65 |
Ratios
Profitability Ratios
| Neogen Chemicals | Atul | DCM Shriram | Foseco India | Grauer & Weil | |
|---|---|---|---|---|---|
|
ROCE (%)
|
6.64 | 15.05 | 11.72 | 15.35 | 21.55 |
|
ROE (%)
|
3.58 | 11.66 | 11.63 | 10.87 | 16.23 |
|
ROA (%)
|
1.24 | 9.09 | 5.51 | 8.10 | 12.02 |
|
EBIT Margin (%)
|
16.64 | 19.66 | 12.51 | 21.90 | 20.50 |
|
Net Margin (%)
|
3.31 | 10.64 | 6.21 | 11.34 | 13.23 |
|
Cash Profit Margin (%)
|
6.51 | 15.71 | 9.19 | 13.59 | 14.58 |
Growth Ratios
| Neogen Chemicals | Atul | DCM Shriram | Foseco India | Grauer & Weil | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
10.85 | 12.36 | 12.10 | 22.61 | 5.02 |
|
EBIT Growth (%)
|
2.21 | 20.71 | 15.03 | 29.61 | 3.57 |
|
Net Profit Growth (%)
|
-17.46 | 38.20 | 41.66 | 2.52 | 4.34 |
|
EPS Growth (%)
|
-17.46 | 40.08 | 41.23 | -16.13 | 4.34 |
|
Book Value Growth (%)
|
3.41 | 11.14 | 10.11 | 202.74 | 15.15 |
Valuation Ratios
| Neogen Chemicals | Atul | DCM Shriram | Foseco India | Grauer & Weil | |
|---|---|---|---|---|---|
|
Price / Earnings
|
102.04 | 27.68 | 20.43 | 50.96 | 15.00 |
|
Price / Book Value
|
3.59 | 3.02 | 2.26 | 3.56 | 2.28 |
|
Dividend Yield (%)
|
0.09 | 0.47 | 1.00 | 0.51 | 0.92 |
|
EV/EBITDA
|
29.69 | 15.28 | 11.45 | 23.82 | 9.16 |
|
Market Cap (₹ Cr)
|
2,933.68 | 18,762.28 | 17,435.78 | 3,683.51 | 2,460.63 |
Solvency Ratios
| Neogen Chemicals | Atul | DCM Shriram | Foseco India | Grauer & Weil | |
|---|---|---|---|---|---|
|
Debt to Equity
|
1.63 | 0.03 | 0.36 | 0.00 | 0.01 |
|
Short term debt to equity ratio
|
0.51 | 0.00 | 0.13 | -- | 0.00 |
|
Current Ratio
|
1.17 | 3.29 | 1.31 | 2.90 | 2.71 |
|
Quick Ratio
|
0.69 | 2.65 | 0.78 | 2.62 | 2.15 |
|
Interest Coverage
|
1.55 | 52.66 | 6.65 | 357.06 | 59.83 |
Operating Efficiency Ratios
| Neogen Chemicals | Atul | DCM Shriram | Foseco India | Grauer & Weil | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
44.13 | 20.26 | 7.99 | 23.84 | 14.75 |
|
Asset Turnover
|
0.37 | 0.85 | 0.95 | 0.70 | 0.95 |
|
Receivable days
|
122.62 | 67.96 | 24.70 | 77.71 | 52.83 |
|
Inventory Days
|
185.31 | 43.79 | 72.95 | 25.57 | 47.31 |
|
Payable days
|
275.96 | 80.97 | 62.67 | 119.23 | 94.89 |
|
Cash Conversion Cycle
|
31.97 | 30.78 | 34.99 | -15.95 | 5.25 |